C-reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, CLIA), By Detection Range, By Disease Area, By End-use, By Region, And Segment Forecasts, 2023 - 2030
- Report ID: GVR-2-68038-129-0
- Number of Pages: 129
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry: Healthcare
Market Segmentation
- C-reactive Protein (CRP) Testing Assay Type Outlook (Revenue, USD Million; 2018 - 2030)
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- C-reactive Protein (CRP) Testing Detection Range Outlook (Revenue, USD Million, 2018 - 2030)
- hs-CRP
- Conventional CRP
- cCRP
- C-reactive Protein (CRP) Testing Disease Area Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- C-reactive Protein (CRP) Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- C-reactive Protein (CRP) Testing Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- North America C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- North America C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- North America C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- U.S.
- U.S. C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- U.S. C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- U.S. C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- U.S. C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- U.S. C-reactive Protein (CRP) Testing Market, By Assay Type
- Canada
- Canada C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Canada C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Canada C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Canada C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Canada C-reactive Protein (CRP) Testing Market, By Assay Type
- North America C-reactive Protein (CRP) Testing Market, By Assay Type
- Europe
- Europe C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Europe C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Europe C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Europe C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Germany
- Germany C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Germany C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Germany C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Germany C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Germany C-reactive Protein (CRP) Testing Market, By Assay Type
- UK
- UK C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- UK C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- UK C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- UK C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- UK C-reactive Protein (CRP) Testing Market, By Assay Type
- France
- France C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- France C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- France C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- France C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- France C-reactive Protein (CRP) Testing Market, By Assay Type
- Italy
- Italy C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Italy C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Italy C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Italy C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Italy C-reactive Protein (CRP) Testing Market, By Assay Type
- Spain
- Spain C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Spain C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Spain C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Spain C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Spain C-reactive Protein (CRP) Testing Market, By Assay Type
- Sweden
- Sweden C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Sweden C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Sweden C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Sweden C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Sweden C-reactive Protein (CRP) Testing Market, By Assay Type
- Denmark
- Denmark C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Denmark C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Denmark C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Denmark C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Denmark C-reactive Protein (CRP) Testing Market, By Assay Type
- Norway
- Norway C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Norway C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Norway C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Norway C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Norway C-reactive Protein (CRP) Testing Market, By Assay Type
- Europe C-reactive Protein (CRP) Testing Market, By Assay Type
- Asia Pacific
- Asia Pacific C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Asia Pacific C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Asia Pacific C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Asia Pacific C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- China
- China C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- China C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- China C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- China C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- China C-reactive Protein (CRP) Testing Market, By Assay Type
- Japan
- Japan C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Japan C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Japan C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Japan C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Japan C-reactive Protein (CRP) Testing Market, By Assay Type
- India
- India C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- India C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- India C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- India C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- India C-reactive Protein (CRP) Testing Market, By Assay Type
- Australia
- Australia C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Australia C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Australia C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Australia C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Australia C-reactive Protein (CRP) Testing Market, By Assay Type
- South Korea
- South Korea C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- South Korea C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- South Korea C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- South Korea C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- South Korea C-reactive Protein (CRP) Testing Market, By Assay Type
- Thailand
- Thailand C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Thailand C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Thailand C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Thailand C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Thailand C-reactive Protein (CRP) Testing Market, By Assay Type
- Asia Pacific C-reactive Protein (CRP) Testing Market, By Assay Type
- Latin America
- Latin America C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Latin America C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Latin America C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Latin America C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Brazil
- Brazil C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Brazil C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Brazil C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Brazil C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Brazil C-reactive Protein (CRP) Testing Market, By Assay Type
- Mexico
- Mexico C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Mexico C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Mexico C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Mexico C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Mexico C-reactive Protein (CRP) Testing Market, By Assay Type
- Argentina
- Argentina C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Argentina C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Argentina C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Argentina C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Argentina C-reactive Protein (CRP) Testing Market, By Assay Type
- Latin America C-reactive Protein (CRP) Testing Market, By Assay Type
- Middle East and Africa (MEA)
- MEA C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- MEA C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- MEA C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- MEA C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- South Africa
- South Africa C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- South Africa C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- South Africa C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- South Africa C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- South Africa C-reactive Protein (CRP) Testing Market, By Assay Type
- Saudi Arabia
- Saudi Arabia C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Saudi Arabia C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Saudi Arabia C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Saudi Arabia C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Saudi Arabia C-reactive Protein (CRP) Testing Market, By Assay Type
- UAE
- UAE C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- UAE C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- UAE C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- UAE C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- UAE C-reactive Protein (CRP) Testing Market, By Assay Type
- Kuwait
- Kuwait C-reactive Protein (CRP) Testing Market, By Assay Type
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
- Kuwait C-reactive Protein (CRP) Testing Market, By Detection Range
- hs-CRP
- Conventional CRP
- cCRP
- Kuwait C-reactive Protein (CRP) Testing Market, By Disease Area
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
- Kuwait C-reactive Protein (CRP) Testing Market, By End-use
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- By Entity
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- Clinics
- Kuwait C-reactive Protein (CRP) Testing Market, By Assay Type
- MEA C-reactive Protein (CRP) Testing Market, By Assay Type
- North America
C-reactive Protein Testing Market Dynamics
Driver: Increasing R&D In The Field Of C-Reactive Protein Testing
The extensive research activities in the field of protein testing by various public & private organizations are major factors driving the market. The development of point-of-care diagnostics that allow patients to undertake CRP testing is also expected to boost the market growth in the near future. Paper-based diagnostics, which are portable and easy-to-use devices for detection of C-reactive proteins have been introduced. Paper-based CRP testing devices are based on use wax technique. This helps define hydrophobic boundaries for fluidic & point-of-care devices and results in reduced manufacturing and overall operation cost of testing. These tests are capable of measuring serum stain length inside the paper-micro channel. These tests usually take 5 min per assay, which is lower than 3 to 4 h taken by traditional lab-based CRP tests.
Driver: Rising Incidence Of Chronic Disorders
Increasing cases of inflammatory disorders is a major factor driving the CRP testing market. According to National Center for Health Statistics, in 2020, around 690,882 individuals died due to heart-related diseases in the U.S. alone. Around 121.5 million adults have some form of cardiovascular disease and more than 130 million adults are projected to have some type of heart disease by 2035. According to the WHO, cancer is one of the major causes of mortality & morbidity, being the second most common cause of death. Around 10.0 million cancer deaths and 19.3 million new cancer cases were estimated to be reported in 2020 across the globe. Breast cancer was estimated to be the most commonly diagnosed cancer with 2.3 million new cases, followed by lung cancer with 11.4% share in total worldwide cases.
Restraint: Availability Of Alternative Disease Testing Methods
Today, there are a number of blood tests available for detection of cardiovascular disorders. These include creatine kinase, myoglobin, cardiac troponin I or T, and creatine kinase-MB. These tests detect unbalanced protein levels in the body, which are associated with heart-related disorders. The availability of alternative testing approaches is expected to hinder the growth of CRP testing market. Cardiac troponin-based tests are sensitive and more specific for cardiac disorders. There are tests that allow quantification of levels of cholesterol and Low-Density Lipoprotein (LDL) & High-Density Lipoprotein (HDL) as well as triglycerides, which are crucial for cardiac risk management and detection of cardiac inflammations. In addition, Erythrocyte Sedimentation Rate (ESR) and Plasma Viscosity (PV) tests are also used for detection of inflammatory disorders in patients.
What Does This Report Include?
This section will provide insights into the contents included in this C-reactive protein testing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
C-reactive protein testing market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
C-reactive protein testing market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
